Increased Surfactant Protein D Fails to Improve Bacterial Clearance and Inflammation in serpinB1−/− Mice
- 1 December 2012
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 47 (6) , 792-799
Abstract
Previously, we described the protective role of the neutrophil serine protease inhibitor serpinB1 in preventing early mortality of Pseudomonas aeruginosa lung infection by fostering bacterial clearance and limiting inflammatory cytokines and proteolytic damage. Surfactant protein D (SP-D), which maintains the antiinflammatory pulmonary environment and mediates bacterial removal, was degraded in infected serpinB1-deficient mice. Based on the hypothesis that increased SP-D would rescue or mitigate the pathological effects of serpinB1 deletion, we generated two serpinB1−/− lines overexpressing lung-specific rat SP-D and inoculated the mice with P. aeruginosa. Contrary to predictions, bacterial counts in the lungs of SP-Dlow serpinB1−/− and SP-Dhigh serpinB1−/− mice were 4 logs higher than wild-type and not different from serpinB1−/− mice. SP-D overexpression also failed to mitigate inflammation (TNF-α), lung injury (free protein, albumin), or excess neutrophil death (free myeloperoxidase, elastase). These pathological markers were higher for infected SP-Dhigh serpinB1−/− mice than for serpinB1−/− mice, although the differences were not significant after controlling for multiple comparisons. The failure of transgenic SP-D to rescue antibacterial defense of serpinB1-deficient mice occurred despite 5-fold or 20-fold increased expression levels, largely normal structure, and dose-dependent bacteria-aggregating activity. SP-D of infected wild-type mice was intact in 43-kD monomers by reducing SDS-PAGE. By contrast, proteolytic fragments of 35, 17, and 8 kD were found in infected SP-Dlow serpinB1−/−, SP-Dhigh serpinB1−/− mice, and serpinB1−/− mice. Thus, although therapies to increase lung concentration of SP-D may have beneficial applications, the findings suggest that therapy with SP-D may not be beneficial for lung inflammation or infection if the underlying clinical condition includes excess proteolysis.Keywords
This publication has 45 references indexed in Scilit:
- Critical Role of SerpinB1 in Regulating Inflammatory Responses in Pulmonary Influenza InfectionThe Journal of Infectious Diseases, 2011
- Surfactant Protein D-Mediated Decrease of Allergen-Induced Inflammation Is Dependent upon CTLA4The Journal of Immunology, 2010
- Surfactant Protein-D Inhibits Lung Inflammation Caused by Ventilation in Premature Newborn LambsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Myeloperoxidase-dependent Inactivation of Surfactant Protein D in Vitro and in VivoJournal of Biological Chemistry, 2010
- Modification of surfactant protein D by reactive oxygen‐nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivoThe FASEB Journal, 2009
- S-Nitrosylation of Surfactant Protein-D Controls Inflammatory FunctionPLOS Biology, 2008
- Surfactant Protein D Protects against Acute Hyperoxic Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2008
- The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infectionJournal of Experimental Medicine, 2007
- Neutrophil Serine Proteinases Inactivate Surfactant Protein D by Cleaving within a Conserved Subregion of the Carbohydrate Recognition DomainJournal of Biological Chemistry, 2004
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004